Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapy.
The first 15 years of the human immunodeficiency virus type 1 epidemic was characterized by patients progressing to clinical acquired immunodeficiency syndrome and death. The availability of potent antiretrovirals led to the recognition of unique adverse events associated with select drugs. More recent data suggest that end-organ damage may be associated with ongoing viremia. Further understanding of the potential role different drugs and the virus itself has on various organs can enhance the clinician's ability to manage patients in the clinic.
Division of HIV Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Los Angeles, CA 90502 USA.
Eric S
ES
Daar